Saity Pramanick. A Multicenter,Randomized,Double-Blind , Placebo -controlled phase 3 study to evaluate the efficacy and safety of Baricitinib in adult patients with moderate to severe: A topic dermatitis.
Chicago Style (17th ed.) CitationSaity Pramanick. A Multicenter,Randomized,Double-Blind , Placebo -controlled Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients with Moderate to Severe: A Topic Dermatitis.
MLA (9th ed.) CitationSaity Pramanick. A Multicenter,Randomized,Double-Blind , Placebo -controlled Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients with Moderate to Severe: A Topic Dermatitis.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.